Physician profile
Richard Weinstein
NPI 1073549077
$4,450.94
in general payments reported to CMS, 2019-2025
23 companies · $6.31 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,224 · 2020: $365 · 2021: $435 · 2022: $446 · 2023: $723 · 2024: $251 · 2025: $6.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $696.12 | 2019-2024 | Camzyos, Eliquis |
| Amgen INC. | $618.28 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $456.47 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $347.88 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $325.71 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $307.72 | 2019-2024 | Brilinta, Lokelma |
| Pfizer INC. | $258.59 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $224.02 | 2021-2023 | Verquvo |
| Amarin Pharma, INC. | $185.04 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $180.44 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $172.29 | 2019-2023 | Evkeeza |
| Esperion Therapeutics, INC. | $115.27 | 2020-2021 | |
| Novo Nordisk INC | $108.94 | 2019-2024 | Ozempic, Rybelsus |
| Kiniksa Pharmaceuticals, Ltd. | $80.51 | 2022-2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $77.66 | 2019-2024 | Xarelto |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $73.44 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $69.27 | 2023-2024 | Inpefa |
| Astellas Pharma US INC | $40.05 | 2019 | |
| Irhythm Technologies, INC. | $38.74 | 2022-2024 | Zio Monitor, Zio Xt Patch |
| Abbott Laboratories | $24.72 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $21.63 | 2024 | Arcalyst |
| Tactile Systems Technology INC | $15.37 | 2019 | |
| United Therapeutics Corporation | $12.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.